Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xenon Ophthalmics is a private ophthalmic medical device and digital health company developing wearable, medical-grade vision diagnostic systems for eye care providers. The company was originally founded as Xenon-VR and officially changed its name to Xenon Ophthalmics in December 2022. Its products combine headset-based eye testing, software, cloud connectivity, artificial intelligence, machine learning, eye-tracking, and liquid lens technology to support refraction, visual field testing, and remote eye exams. Xenon markets the XO Vision Care System and XO Exam product family as integrated tools intended to improve throughput, expand access to care, and support telehealth-enabled ophthalmic workflows. The business appears focused on commercialization rather than drug development, serving ophthalmologists, optometrists, clinics, and broader eye care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xenon Ophthalmics.